This post was originally published on this site
Given the historically high inflation, supply chain constraints, and ongoing volatility in the broader market, investors and analysts are anticipating a market correction in the near term. However, the inelastic demand for healthcare products should help the industry participants to deliver substantial returns and hedge the current market risks. Global healthcare spending is expected to reach $10.06 trillion by 2022.
Given this backdrop, we believe it is wise to bet on quality healthcare stocks Merck & Co., Inc. (MRK), Novartis AG (NVS), Zoetis Inc . (NYSE:ZTS), and Cerner Corporation (NASDAQ:CERN) that have the potential to deliver solid returns and dodging the market fluctuations.
